| NF1 |
Neurofibromatosis type 1 |
Mostly adrenal (bilateral) |
12% |
Neurofibromas, malignant tumors of the peripheral nerve sheath, optic gliomas and leukemias |
| RET |
Multiple endocrine neoplasia type 2 |
Adrenal (bilateral) |
<5% |
Medullary thyroid carcinoma, parathyroid adenomas/ hyperplasia |
| VHL |
von Hippel Lindau |
Mostly adrenal (bilateral) |
5-8 % |
Renal clear cell (RCC) carcinoma, neuroendocrine tumors of the pancreas (mostly non-functioning), CNS hemangioblastomas, endolymphatic sac tumors, pituitary adenomas |
| SDHA |
Hereditary PGL syndrome |
Any |
30-60% |
RCC carcinoma, gastro-intestinal stromal tumors (GIST) and pituitary adenomas |
| SDHB |
Hereditary PGL syndrome |
Any, mostly extra-adrenal |
35-75% |
RCC carcinoma, GIST and pituitary adenomas |
| SDHC |
Hereditary PGL syndrome |
Head and neck, can be thoracic |
Low |
RCC carcinoma, GIST and pituitary adenomas |
| SDHD |
Hereditary PGL syndrome |
Any, mostly head and neck |
15-29% |
RCC carcinoma, GIST and pituitary adenomas |
| SDHAF 2 (SDH5) |
Hereditary PGL syndrome |
Head and neck (multifocal) |
Not Known |
RCC carcinoma, GIST and pituitary adenoma |
| TMEM 127 |
Familial PGL syndrome |
Any, mostly adrenal |
Low |
RCC carcinoma |
| MAX |
Familial PGL syndrome |
Mostly adrenal (bilateral) |
Intermediate to high |
Pituitary adenomas |
| EPAS1 |
Familial PGL syndrome, polycythemia |
Any |
Unknown |
Somatostatinoma |
| FH |
Hereditary leiomatosis, RCC carcinoma |
Any |
Possibly high |
Cutaneous and uterine leiomyomas, renal papillary carcinoma |
| MDH2 |
|
Any |
Unknown |
|